Skip to main content
  1. Ethical Science News

  2. Sep 19, 2024

Researchers Use Organ-on-a-Chip Technology as a New Model for Liver Cancer Therapies

Study in a Sentence: A novel liver-on-a-chip model can be used to study immune cell interactions in liver cancer and test promising new therapies.

Healthy for Humans: The most common form of liver cancer, hepatocellular cancer, is resistant to conventional cancer therapies and a leading cause of cancer deaths. Although there has been some success with immunotherapy, which uses a patient’s own immune system to fight the cancer, it still does not work for the majority of patients and new therapies are needed.

Redefining Research: This new disease model combines human liver and immune cells in an organ-on-a-chip platform, capturing important biological characteristics of hepatocellular cancer. Researchers successfully demonstrate cellular interactions in the tumor microenvironment, establishing a foundation for developing and testing novel immunotherapies.

References

Kennedy JI, Davies SP, Hewett PW, et al. Organ-on-a-chip for studying immune cell adhesion to liver sinusoidal endothelial cells: the potential for testing immunotherapies and cell therapy trafficking. Frontiers in Cell and Developmental biology. 2024;12. https://doi.org/10.3389/fcell.2024.1359451.

More on Ethical Science